Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nanalysis Scientific Corp. V.NSCI

Alternate Symbol(s):  NSCIF

Nanalysis Scientific Corp. develops and manufactures portable Nuclear Magnetic Resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The Company’s segments include Scientific Equipment and Security Services. Scientific Equipment segment conducts scientific equipment manufacturing and sales, primarily as a patent-protected technology Company that develops, manufactures, and sells magnetic resonance (MR) products for security, pharmaceutical, biotech, nutraceutical, chemical, food, materials, education, life science and medical applications. Security Services, focuses on providing security services, namely providing preventative and oncall maintenance services, as well as installation, of detection and analysis equipment. It offers commercial security equipment installation and maintenance services to a variety of customers in North America. It provides airport security equipment maintenance services in each province and territory of Canada.


TSXV:NSCI - Post by User

Comment by Baconatoron Jul 27, 2021 12:36am
98 Views
Post# 33608806

RE:Stonegate Research Report released.

RE:Stonegate Research Report released.

Nicely done. Conservative revenue number used for 2022 at 28.1 million. Considering they hope to ramp up their manufacturing to 40 million per year capacity, as well as having the only 100 MHz NMR product in the market to support the pipeline, seems to be very achievable. Low end current valuation of $1.27 offers good support and limited downside which should help boost the price a bit closer to the $2.10 mid point valuation. 


It will be curious to see how the market responds tomorrow (if at all). I'm in this for the long, so loving this year so far. Well managed, nice little company that will turn some heads in the short term IMO. 

<< Previous
Bullboard Posts
Next >>